Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FT242
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,702
Award facts
- Contract value 100% obligated
- $13,702.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $13,702.49, represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 24, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999 through December 2026 that enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal vendor for medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical supply requirements, ranging from specialty medications and brand-name drugs to vaccines and medical devices across multiple therapeutic domains. This delivery order for Xeljanz XR—a treatment for rheumatoid arthritis and other autoimmune conditions—is consistent with the company's role as a primary pharmaceutical supplier within the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DR26FT242?
SPE2DR26FT242 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DR26FT242 worth?
The government has obligated $13,702 on SPE2DR26FT242.
Is contract SPE2DR26FT242 an order under another contract?
Yes. SPE2DR26FT242 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FT242 competed?
The extent of competition for SPE2DR26FT242 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award